Provided by Tiger Trade Technology Pte. Ltd.

Veracyte

41.47
-0.8400-1.99%
Post-market: 41.510.0400+0.10%19:59 EDT
Volume:1.17M
Turnover:48.28M
Market Cap:3.33B
PE:29.74
High:42.07
Open:42.00
Low:41.02
Close:42.31
52wk High:60.91
52wk Low:28.25
Shares:80.39M
Float Shares:78.97M
Volume Ratio:0.90
T/O Rate:1.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.39
EPS(LYR):0.8200
ROE:8.77%
ROA:4.09%
PB:2.40
PE(LYR):50.57

Loading ...

Veracyte Is Maintained at Buy by Guggenheim

Dow Jones
·
Mar 30

Veracyte price target lowered to $45 from $50 at Guggenheim

TIPRANKS
·
Mar 30

Veracyte files initial beneficial ownership statement; Chief Dev and Tech Officer Kevin Richard Haas reports no securities beneficially owned

Reuters
·
Mar 26

Veracyte Appoints Kevin Haas as Chief Technology Leader

TIPRANKS
·
Mar 17

Veracyte Appoints Kevin Haas as Chief Development and Technology Officer

MT Newswires Live
·
Mar 17

Veracyte appoints Kevin Haas as chief development and technology officer

Reuters
·
Mar 17

Veracyte CEO Marc Stapley Reports Disposal of Common Shares

Reuters
·
Mar 07

Veracyte CFO Rebecca Chambers Disposes of Common Shares

Reuters
·
Mar 07

Veracyte SVP and General Counsel Annie McGuire Disposes of Common Shares

Reuters
·
Mar 07

Veracyte Is Maintained at Underweight by Morgan Stanley

Dow Jones
·
Mar 07

Morgan Stanley Lowers Price Target on Veracyte to $37 From $48, Keeps Underweight Rating

MT Newswires Live
·
Mar 06

Veracyte Chief Scientific and Medical Officer Phillip G. Febbo Disposes of Common Shares

Reuters
·
Mar 05

Veracyte Inc. Signals Durable Growth in Earnings Call

TIPRANKS
·
Mar 03

How Veracyte’s Profit Jump and 2026 Outlook Will Impact Veracyte (VCYT) Investors

Simply Wall St.
·
Mar 01

Veracyte (VCYT) Gets a Buy from Craig-Hallum

TIPRANKS
·
Feb 28

Stock Track | Veracyte Soars 7.81% Intraday Following Analyst Price Target Hike and Pipeline Updates

Stock Track
·
Feb 26

Needham Raises Price Target on Veracyte to $48 From $44, Keeps Buy Rating

MT Newswires Live
·
Feb 26

Veracyte’s ASCO Urology Data And TrueMRD Launch Test Investor Patience

Simply Wall St.
·
Feb 26

Veracyte Is Maintained at Buy by Needham

Dow Jones
·
Feb 26

Stock Track | Veracyte Soars 6.08% in Pre-market After Analyst Raises Price Target to $48

Stock Track
·
Feb 26